26
Participants
Start Date
December 31, 2006
Primary Completion Date
January 31, 2010
Study Completion Date
January 31, 2010
FERINJECT® (Ferric carboxymaltose)
FERINJECT® will be administered i.v. into a peripheral vein in the arm. 500 mg FERINJECT® will be diluted to a total volume of 100mL in 0.9% saline for infusion and administered over 15 minutes duration.
Placebo
Placebo will be administered i.v. into a peripheral vein in the arm. A total volume of 100mL 0.9% saline will be administered over 15 minutes duration.
Univ. clinic for Internal Medicine, Vienna
Lead Sponsor
Vifor Pharma
INDUSTRY